Indications |
Oral Pain and inflammation Adult: 1.2-1.8 g/day in divided doses. Maintenance: 0.6-1.2 g daily. Max: 2.4 g per day. Oral Juvenile idiopathic arthritis Child: ≥3 mth and weighing >5 kg: 30-40 mg/kg/day in 3-4 divided doses. Max: 2.4 g/day. Oral Fever Adult: 200-400 mg every 4-6 hr. Max: 1.2 g/day. Child: 1-6 mth: 5 mg/kg 3-4 times daily, 6-12 mth: 50 mg 3 times daily, 1-2 yr: 50 mg 3-4 times daily, 2-7 yr: 100 mg 3-4 times daily, >7 yr: 200 mg 3-4 times daily. Max: 40 mg/kg/day. Intravenous Closure of patent ductus arteriosus Child: Given as three IV doses infused over 15 minutes at 24-hr intervals. Initially 10 mg/kg followed by two doses of 5 mg/kg. A second course may be given if ductus remains open after 48 hr. Surgery may be required if neonate is unreponsive to 2 courses of treatment. Dose should be based on birth weight. Topical/Cutaneous Pain and inflammation associated with musculoskeletal and joint disorders Adult: As 5% or 10% gel: Apply onto affected area. Special Populations: Dose reduction in renal and hepatic impairment. Patients who developed severe mucositis during the 1st course of therapy: Reduce the 2nd course dose to 25%. |
Contraindications |
Active peptic ulcer; hypersensitivity. Neonates with congenital heart disease, suspected necrotising enterocolitis and active bleeding (parenteral). |
Warnings / Precautions |
Asthma; renal or hepatic disorders; bleeding disorders; CV disease. Pregnancy, lactation. |
Adverse Reactions |
Oral: Dyspepsia, vomitting, abdominal pain, heart burn, nausea, diarrhoea, epigastric pain, edema, fluid retention, dizziness, rash, tinnitus. Parenteral: Intraventricular hemorrhage, skin irritation, hypocalcemia, hypoglycemia, GI disorders, anemia, apnea, respiratory infection, sepsis. Potentially Fatal: Severe CV thrombotic events. Severe GI bleeding, ulceration and perforation. |
Overdose Reactions |
Symptoms: Apnoea, metabolic acidosis, coma, nystagmus, seizures, leukocytosis and renal failure. Management: Supportive and symptomatic. Multiple doses of charcoal may be required. |
Drug Interactions |
Reduces effects of antihypertensives. Enhanced effect with moclobemide. Increased risk of GI bleeding with warfarin. Potentially Fatal: Reduces antiplatelet effect of aspirin. Increases risk of methotrexate and lithium toxicity. See Below for More ibuprofen Drug Interactions |
Food Interactions |
Decreased peak serum levels if taken with food. |
Mechanism of Actions |
Ibuprofen exhibits anti-inflammatory, analgesic and antipyretic activities. Its analgesic effect is independent of anti-inflammatory activity and has both central and peripheral effects. It potently inhibits the enzyme cyclooxygenase resulting in the blockage of prostaglandin synthesis. It also prevents formation of thromboxane A2 by platelet aggregation. Onset: Analgesic: 30-60 min. Anti-inflammatory: ≤7 days. Duration: 4-6 hr. Absorption: Oral: Peak plasma concentrations after 1-2 hr. Topical: Minimal. Distribution: Protein-binding: 90-99%. Metabolism: Hepatic via oxidation. Excretion: Via urine (1% as free drug), some feces; 2 hr (plasma half-life). |
Administration |
Should be taken with food. |
Storage Conditions |
Intravenous: Store at room temperature of 20-25°C (68-77°F). Oral: Cap/Gelcap/Tab: Store at room temperature of 20-25°C (68-77°F). Susp/Drops: Store at room temperature of 15-30°C (59-86°F). |
ATC Classification |
C01EB16 - ibuprofen ; Belongs to the class of other cardiac preparations. G02CC01 - ibuprofen ; Belongs to the class of antiinflammatory products for vaginal administration used in the treatment and prevention of inflammation. M01AE01 - ibuprofen ; Belongs to the class of propionic acid derivatives of non-steroidal antiinflammatory and antirheumatic products. M02AA13 - ibuprofen ; Belongs to the class of non-steroidal antiinflammatory preparations for topical use. Used in the treatment of joint and muscular pains. |
Storage |
Intravenous: Store at room temperature of 20-25°C (68-77°F). Oral: Cap/Gelcap/Tab: Store at room temperature of 20-25°C (68-77°F). Susp/Drops: Store at room temperature of 15-30°C (59-86°F). |
Available As |
|
Ibuprofen
Post Review about Ibuprofen Click here to cancel reply.
Ibuprofen Containing Brands
Ibuprofen is used in following diseases
Drug - Drug Interactions of Ibuprofen
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.